PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 4744: Metabolomic profiling of fresh and formalin-fixed paraffin-embedded samples reveals metabolome alterations in penile cancer

View Full Paper
AHAndres Enrique Hernandez-GonzalezMSMaría M. Sánchez-VázquezLTLuis Torres-Peña

Key Points

  • The study aims to analyze metabolomic profiles of penile cancer samples and explore their correlation with clinical variables.
  • Characterization of non-targeted metabolomic profiles of fresh and FFPE penile cancer samples.
  • HPV infection status was determined using commercial HPV genotyping kits.
  • Metabolites were analyzed using GCMS/MS-TQ8050 equipment.
  • Statistical analysis conducted with T-tests and Mann-Whitney tests using MetaboAnalyst 6.0.
  • Fresh samples yielded 52 metabolites; FFPE samples yielded 18 metabolites.
  • Significant correlations found between HPV infection status, tumor stage, and various metabolites.
  • Key metabolites include isoleucine, homoserine, cysteine, glycolic acid, methylmalonic acid, malic acid, and heptanoic acid with p-values < 0.05.
  • No significant correlation identified between tumor grade and metabolomic alterations.

Abstract

Abstract Penile squamous cell carcinoma represents a significant source of morbidity and mortality in Puerto Rico, with HPV-associated cases comprising 56% of cases. The link between clinical variables and metabolomic alterations has not been studied in penile cancer. This study aimed to characterize the non-targeted metabolomic profiles of fresh and formalin-fixed paraffin-embedded (FFPE) penile cancer samples to identify correlations with patient clinical variables: HPV infection status, tumor stage and tumor grade. In this study, 14 fresh and 37 FFPE penile cancer samples were processed for metabolomic analysis. HPV infection status was determined using INNO-Lipa HPV Genotyping and RHA kit HPV SPF10-LiPA25 kits. Sample aliquots were analyzed using GCMS/MS-TQ8050 equipment. Clinical variables were provided by the Departments of Pathology and Surgery. Filtering of raw data was conducted using AMDIS 32 and the NIST MS Spectrum database. Statistical analysis (T-test and Mann-Whitney test) of metabolomic profiles was done using MetaboAnalyst 6.0. Our study identified 52 metabolites in the fresh penile cancer sample cohort and 18 metabolites in the FFPE penile cancer sample cohort. The fresh sample cohort yielded eight metabolite classes: amino acids, sugar alcohols, fatty acids, carboxylic acids, nucleic acids, sterols, cofactor and vitamins, and others. The FFPE cohort yielded five metabolite classes: amino acids, sugar alcohols, fatty acids, carboxylic acids, and others. Statistical findings suggest that HPV infection status and tumor stage are significantly correlated with alterations in expression of several metabolites in both sample cohorts: isoleucine (p value = 0.011), homoserine (p-value = 0.0001), cysteine (p-value = 0.0385), glycolic acid (p-value = 0.0215), methylmalonic acid (p-value = 0.0475), malic acid (p-value = 0.0483) and heptanoic acid (p-value = 0.0461). Statistical findings found no significant correlation between tumor grade and metabolomic alterations. Our findings suggest that HPV infection status and tumor stage are associated with altered metabolomic pathways in penile cancer. Further understanding is needed to establish the clinical relevance of these altered metabolites and their potential role as novel metabolomic biomarkers or therapeutic targets to improve treatment outcomes for this disease. Citation Format: Andres Enrique Hernandez-Gonzalez, Maria Sanchez-Vazquez, Luis Torres-Peña, Keren Valentin-Lopez, Carlos A. Rivera-López, Brandon Torres-Rivera, Maria Marcos-Martinez, Antonio Puras-Baez, Nataliya Chorna, Magaly Martinez-Ferrer. Metabolomic profiling of fresh and formalin-fixed paraffin-embedded samples reveals metabolome alterations in penile cancer abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4744.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hernandez-Gonzalez et al. (2026) studied this question.

synapsesocial.com/papers/69d1fdb0a79560c99a0a3ed1https://doi.org/10.1158/1538-7445.am2026-4744
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 4403: The crosstalk between the tumor microbiome and epigenomic changes in penile squamous cell carcinoma2024
  2. 2Abstract 4710: Comprehensive metabolomic profiling of FFPE human tissues reveals key metabolic reprogramming in colorectal cancer and associated pathways2026
  3. 3Abstract 4703: Sex-specific metabolic features in pre-cancerous polyps identified in Puerto Rican stool samples: A pilot study2026
  4. 4Abstract 3427: Serum metabolites and pancreatic ductal adenocarcinoma in two prospective cohorts2024
  5. 5Proteomic and Metabolomic Analyses of HPV-Positive High-Grade Squamous Intraepithelial Lesions2026